Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGoodwin Regulatory News (GDWN)

Share Price Information for Goodwin (GDWN)

Share Price is delayed by 15 minutes
Get Live Data
14,740.00    200.00 (1.38%)
Bid:
14,720.00
Ask:
14,820.00
Spread: 100.00 (0.679%)
Market Cap: £1.12b
GDWN Live PriceLast checked at - London Stock Exchange

Intraday Goodwin Share Chart

September 2024 Trading Update

25 Sep 2024 10:32

RNS Number : 6252F
Goodwin PLC
25 September 2024
 

GOODWIN PLC

SEPTEMBER 2024 TRADING UPDATE

Trading

 

The Group's profitability and cash generation is continuing to move forward, predominantly driven by the Mechanical Engineering Division's increased activity levels of work flowing through the shop floor. The performance within the Refractory Engineering Division remains in line with last year. 

 

Radiography Facility

Goodwin Steel Castings (GSC) has continued to win further contracts to supply naval hull components, which has contributed to the Group workload as at the end of August having increased to £298 million. As a direct result of the workload at GSC to supply high integrity castings, which typically require a high degree of radiography non-destructive testing, the US Government has agreed to fully fund the capital and training elements for a quantity of four High Power 9 Mev radiographic facilities that will be installed on GSC's site and in doing so has awarded GSC $14.5 million of grant funding.

This award allows us to increase our capacity to process and test the increased volume of castings that have already been placed, along with additional components that are expected to be ordered and delivered within their desired timeframes. The facilities will be owned and operated by GSC and are expected to be fully operational by the end of 2025. These compliment the two existing radiography facilities on GSC's site that currently operate 24 hours a day, 7 days a week.

Duvelco

Commissioning of the polyimide production plant is methodically underway and progressing. This is a couple of months behind the internal schedule set 4 years ago. To date the system has been fully tested with water where it can be and is now being charged with solvents that will enable the testing of the back end of the system. A further update will be provided within the half year statement in December.

Appointment of Non-Executive Director

To further support the growth of the Group, it is a pleasure to announce the appointment of Christine McNamara as a Non-Executive Director with effect from the 2nd October 2024 following the Annual General Meeting.

Christine comes with an extensive and varied career within the energy and power sector. As a qualified accountant she has held multiple FD/CFO roles within large corporates, including Powergen, National Grid PLC and BG Group plc (purchased by Shell plc in 2016). In addition to sitting on multiple boards and committees, Christine's executive career has been hands on with her having spent over 17 years overseas growing regional businesses in Asia and the Middle East. Christine's responsibilities during her 25 years' experience have included financial strategy, business performance, governance, audit and risk management.

Following a thorough induction to the business over the last 4 months, we are confident that her extensive listed company experience and exposure to a variety of business aspects will be of significant benefit to the Company.

There is no information to be disclosed pursuant to Listing Rule UKLR 6.4.8 in respect of the appointed Director.

T.J.W. Goodwin

Chairman

 

END

LEI: 213800N4T1NMSJ57B322

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTLAMLTMTTTMLI
Date   Source Headline
23rd Mar 20269:19 amRNSTrading Update
16th Dec 20257:00 amRNSHalf-year Report
18th Nov 20257:00 amRNSDirector/PDMR Shareholding
14th Nov 20257:00 amRNSPLACING OF SHARES IN GOODWIN PLC
27th Oct 20257:00 amRNSTrading Update
1st Oct 20253:56 pmRNSResult of AGM
24th Sep 20258:16 amRNSTrading Update & Strategic Collaboration Agreement
14th Aug 202511:42 amRNSPosting of Annual Report and Accounts
30th Jul 20257:00 amRNSPreliminary results for the year ended 30 Apr 2025
12th May 20257:00 amRNSChanges to the Audit Committee
9th Apr 202511:00 amRNSDirector/PDMR Shareholding
19th Mar 20258:00 amRNSMarch 2025 Trading Update
18th Feb 20258:49 amRNSDirector/PDMR Shareholding
17th Dec 20247:00 amRNSHalf-year Report
7th Oct 20247:00 amRNSAppointment of Joint Corporate Broker
2nd Oct 20243:03 pmRNSResult of AGM
25th Sep 202410:32 amRNSSeptember 2024 Trading Update
22nd Aug 20243:35 pmRNSPosting of Annual Report and Accounts
7th Aug 20247:00 amRNSPreliminary results for the year ended 30 Apr 2024
3rd Jul 20246:00 pmRNSSmurfit Kappa Group - Update
3rd Jun 20244:21 pmRNSDirector/PDMR Shareholding
15th Apr 20243:02 pmRNSDirector/PDMR Shareholding
28th Mar 20242:12 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSMarch 2024 Trading Update
20th Dec 20237:00 amRNSHalf-year Report
23rd Nov 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20233:12 pmRNSDirector/PDMR Shareholding
29th Aug 20234:02 pmRNSPosting of Annual Report and Accounts
8th Aug 20237:00 amRNSPreliminary results for the year ended 30 Apr 2023
30th Jun 20237:00 amRNSTotal Voting Rights
5th Jun 20237:00 amRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSResult of Tender Offer, TVR & Directors' interests
30th May 20232:39 pmRNSResult of General Meeting
5th May 20231:05 pmRNSProposed Tender Offer
3rd Apr 20237:00 amRNSDirector Retirement
10th Jan 20237:00 amRNSDirector/PDMR Shareholding
22nd Dec 202210:34 amRNSDirector/PDMR Shareholding
20th Dec 20227:00 amRNSHalf-year Report
22nd Nov 20224:35 pmRNSPrice Monitoring Extension
14th Oct 20227:00 amRNSDirector/PDMR Shareholding
5th Oct 20222:54 pmRNSResult of AGM
31st Aug 20224:41 pmRNSSecond Price Monitoring Extn
31st Aug 20224:35 pmRNSPrice Monitoring Extension
19th Aug 20222:38 pmRNSPosting of Annual Report and Accounts
3rd Aug 20227:00 amRNSFinal Results
6th Apr 202212:28 pmRNSDirector/PDMR Shareholding
15th Dec 20217:00 amRNSHalf-year Report
18th Oct 20214:07 pmRNSDirector/PDMR Shareholding
15th Oct 20214:40 pmRNSSecond Price Monitoring Extn
15th Oct 20214:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.